SQZ Biotechnologies Co Quarterly Debt-to-equity in % from Q2 2021 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SQZ Biotechnologies Co quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2023.
  • SQZ Biotechnologies Co Debt-to-equity for the quarter ending September 30, 2023 was 108 %, a 10.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 108 +10.1 +10.3% Sep 30, 2023
Q2 2023 101 +11.6 +13% Jun 30, 2023
Q1 2023 100 +23.4 +30.4% Mar 31, 2023
Q4 2022 99.4 +31.7 +46.7% Dec 31, 2022
Q3 2022 97.6 +29.9 +44.2% Sep 30, 2022
Q2 2022 89.1 -24 -21.2% Jun 30, 2022
Q1 2022 76.7 Mar 31, 2022
Q4 2021 67.8 Dec 31, 2021
Q3 2021 67.7 Sep 30, 2021
Q2 2021 113 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.